Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$20.50+0.91 (+4.65%)
Close on Nov 18, 2026Market cap $1.98BP/E –Yield –
Fortrea operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Fortrea's operating income for the twelve months ending Sep 30, 2026 was $12.80M. For fiscal 2025 it was -$872.60M. The highest annual figure on record is $187.10M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$872.60M | – |
| FY2024 | Dec 31, 2024 | -$161.90M | -605.9% |
| FY2023 | Dec 31, 2023 | $32.00M | -82.9% |
| FY2022 | Dec 31, 2022 | $187.10M | +63.7% |
| FY2021 | Dec 31, 2021 | $114.30M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.00M | – |
| Q2 FY2026 | Jun 30, 2026 | $14.80M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.40M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.60M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$330.30M | – |
| Q1 FY2025 | Mar 31, 2025 | -$520.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$55.60M | – |
| Q3 FY2024 | Sep 30, 2024 | -$18.00M | -274.8% |
| Q2 FY2024 | Jun 30, 2024 | -$50.90M | -261.1% |
| Q1 FY2024 | Mar 31, 2024 | -$37.40M | -365.2% |
| Q4 FY2023 | Dec 31, 2023 | -$24.00M | -267.8% |
| Q3 FY2023 | Sep 30, 2023 | $10.30M | -85.1% |
| Q2 FY2023 | Jun 30, 2023 | $31.60M | -55.6% |
| Q1 FY2023 | Mar 31, 2023 | $14.10M | – |
| Q4 FY2022 | Dec 31, 2022 | $14.30M | – |
| Q3 FY2022 | Sep 30, 2022 | $68.90M | – |
| Q2 FY2022 | Jun 30, 2022 | $71.20M | – |
See a number that looks wrong?